##gff-version 3
##sequence-region Q5VWQ8 1 1189
Q5VWQ8	UniProtKB	Chain	1	1189	.	.	.	ID=PRO_0000252407;Note=Disabled homolog 2-interacting protein	
Q5VWQ8	UniProtKB	Domain	101	202	.	.	.	Note=PH;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00145	
Q5VWQ8	UniProtKB	Domain	200	295	.	.	.	Note=C2	
Q5VWQ8	UniProtKB	Domain	371	563	.	.	.	Note=Ras-GAP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00167	
Q5VWQ8	UniProtKB	Region	646	943	.	.	.	Note=Necessary for interaction with AKT1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19903888;Dbxref=PMID:19903888	
Q5VWQ8	UniProtKB	Coiled coil	1026	1159	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q5VWQ8	UniProtKB	Compositional bias	8	52	.	.	.	Note=Arg-rich	
Q5VWQ8	UniProtKB	Compositional bias	112	117	.	.	.	Note=Poly-Ala	
Q5VWQ8	UniProtKB	Compositional bias	867	870	.	.	.	Note=Poly-Ala	
Q5VWQ8	UniProtKB	Compositional bias	903	948	.	.	.	Note=Pro-rich	
Q5VWQ8	UniProtKB	Site	172	173	.	.	.	Note=Breakpoint for translocation to form KMT2A/MLL1-DAB2IP	
Q5VWQ8	UniProtKB	Modified residue	728	728	.	.	.	Note=Phosphoserine%3B by MAP3K5 and RIPK1;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17389591,ECO:0000269|PubMed:19903888;Dbxref=PMID:17389591,PMID:19903888	
Q5VWQ8	UniProtKB	Modified residue	747	747	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VWQ8	UniProtKB	Modified residue	978	978	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:21406692,PMID:23186163	
Q5VWQ8	UniProtKB	Modified residue	995	995	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VWQ8	UniProtKB	Alternative sequence	1	193	.	.	.	ID=VSP_020952;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:11944990;Dbxref=PMID:11944990	
Q5VWQ8	UniProtKB	Alternative sequence	1	124	.	.	.	ID=VSP_020953;Note=In isoform 2 and isoform 4. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11214970,ECO:0000303|PubMed:14978793,ECO:0000303|PubMed:15489334;Dbxref=PMID:11214970,PMID:14978793,PMID:15489334	
Q5VWQ8	UniProtKB	Alternative sequence	2	41	.	.	.	ID=VSP_047361;Note=In isoform 5. SAGGSARKSTGRSSYYYRLLRRPRLQRQRSRSRSRTRPAR->EPDSLLDQDDSY;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VWQ8	UniProtKB	Alternative sequence	1158	1189	.	.	.	ID=VSP_020954;Note=In isoform 3%2C isoform 4 and isoform 5. RYSMQARNGISPTNPTKLQITENGEFRNSSNC->SMH;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11214970,ECO:0000303|PubMed:11944990,ECO:0000303|PubMed:15489334;Dbxref=PMID:11214970,PMID:11944990,PMID:15489334	
Q5VWQ8	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_056858;Note=S->F;Dbxref=dbSNP:rs7027492	
Q5VWQ8	UniProtKB	Mutagenesis	228	230	.	.	.	Note=Reduces interaction with KDR/VEGFR2. Does not inhibit interaction with MAP3K5. KKK->AAA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12813029,ECO:0000269|PubMed:19033661;Dbxref=PMID:12813029,PMID:19033661	
Q5VWQ8	UniProtKB	Mutagenesis	281	284	.	.	.	Note=Significantly reduces interaction with MAP3K5. Does not reduce interaction with KDR/VEGFR2. KKKK->AAAA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12813029,ECO:0000269|PubMed:19033661;Dbxref=PMID:12813029,PMID:19033661	
Q5VWQ8	UniProtKB	Mutagenesis	413	413	.	.	.	Note=Does not inhibit interaction with MAP3K5. Does not reduce GSK3B-induced beta-catenin transcription activity%2C TNF-alpha-induced apoptosis%2C ARF6-mediated TLR4-TIRAP-MyD88 signaling inhibition%2C Ras and NF-kappa-B activities and tumor development. Does not suppress tumor development%3B when associated with A-728. R->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12813029,ECO:0000269|PubMed:19903888,ECO:0000269|PubMed:19948740,ECO:0000269|PubMed:20154697;Dbxref=PMID:12813029,PMID:19903888,PMID:19948740,PMID:20154697	
Q5VWQ8	UniProtKB	Mutagenesis	728	728	.	.	.	Note=Inhibits phosphorylation and TNF-alpha-induced MAP3K5 dephosphorylation. Reduces interaction with 14-3-3 proteins%2C AKT1%2C a regulatory p85 subunit%2C MAP3K5%2C RIPK1%2C TRAF2 and TNF-alpha-induced MAP3K5-JNK signaling and apoptosis. Reduces RAS activity. Does not reduce GSK3B-induced beta catenin-mediated transcription activity. Does not reduce NF-kappa-B activity%2C cell invasion%2C epithelial-to-mesenchymal transition (EMT) and tumor development. Does not suppress tumor development%3B when associated with R-413. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17389591,ECO:0000269|PubMed:18292600,ECO:0000269|PubMed:19903888,ECO:0000269|PubMed:20154697;Dbxref=PMID:17389591,PMID:18292600,PMID:19903888,PMID:20154697	
Q5VWQ8	UniProtKB	Mutagenesis	920	929	.	.	.	Note=Reduces interaction with a regulatory p85 subunit of the PI3K complex. Inhibits MAP3K5 active form increase%2C AKT1 active form decrease%2C PI3K-p85 complex activity inhibition and TNF-induced apoptosis. PPPPPPPPPP->AAAAAAAAAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19903888;Dbxref=PMID:19903888	
Q5VWQ8	UniProtKB	Mutagenesis	935	935	.	.	.	Note=Does not reduce interaction with 14-3-3 proteins. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17389591;Dbxref=PMID:17389591	
Q5VWQ8	UniProtKB	Sequence conflict	482	482	.	.	.	Note=I->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VWQ8	UniProtKB	Sequence conflict	921	921	.	.	.	Note=P->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VWQ8	UniProtKB	Sequence conflict	1091	1092	.	.	.	Note=QQ->HE;Ontology_term=ECO:0000305;evidence=ECO:0000305	
